IL-17A increases ADP-induced platelet aggregation
- 20 May 2011
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 408 (4), 658-662
- https://doi.org/10.1016/j.bbrc.2011.04.080
Abstract
No abstract availableKeywords
Funding Information
- British Heart Foundation grant (PG/06/153/22042)
- The Wellcome Trust (081833/Z/08/Z)
This publication has 28 references indexed in Scilit:
- Pathogenic role of IL-17 in endothelial dysfunction, a link between rheumatoid arthritis and atherosclerosisAnnals Of The Rheumatic Diseases, 2010
- Th17 cytokines and arthritisSeminars in Immunopathology, 2010
- Interleukin‐17 and its target genes: mechanisms of interleukin‐17 function in diseaseImmunology, 2010
- The Role of IL-23/IL-17 Axis in Lupus NephritisThe Journal of Immunology, 2009
- Novel uses for anti‐platelet agents as anti‐inflammatory drugsBritish Journal of Pharmacology, 2007
- Regulation and functional consequences of ADP receptor-mediated ERK2 activation in plateletsBiochemical Journal, 2007
- The role of ADP receptors in platelet functionFrontiers in Bioscience-Landmark, 2006
- Interleukin-17 augments tumor necrosis factor-α-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblastsThe Esophagus, 2005
- Vav1 and Vav3 Have Critical but Redundant Roles in Mediating Platelet Activation by CollagenJournal of Biological Chemistry, 2004
- Platelet GPIb-V-IX ComplexSeminars in Thrombosis and Hemostasis, 1995